On Feb. 20, U.S. Senate Democratic Whip Dick Durbin, D-Ill., and Sen. Roger Marshall, R-Kan., reintroduced the proposed Protecting Patients from Deceptive Drug Ads Act, S. 652, which would authorize the FDA to regulate prescription drug promotions by social media influencers and telehealth companies that are not directly associated with pharma or device companies. Durbin intr... Read More